Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ongini

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Pharmacology, Biochemistry, and Behavior|March 1, 1996
Effects of four antiepileptic drugs on sleep and waking in the rat under both light and dark phasesR Bertorelli, N Ferri, M Adami, et al.
Journal of Neurochemistry|March 7, 1998
[3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studiesB B Fredholm, K Lindström, S Dionisotti, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
Selective adenosine A2A receptor antagonistsE Ongini, A Monopoli, B Cacciari, et al.
European Journal of Pharmacology|February 26, 1991
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brainM Trampus, E Ongini, K Varani, et al.
European Journal of Pharmacology|June 7, 1985
Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the ratJ A Apud, C Masotto, E Ongini, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1987
SCH 23390 and its S-enantiomer stereoselectively prevent EEG and behavioral activation induced by dopamine agonists in the rabbitE Ongini, M G Caporali, M Massotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261S Dionisotti, S Ferrara, C Molta, et al.
Psychopharmacology|January 1, 1992
Effects of remoxipride, a dopamine D-2 antagonist antipsychotic, on sleep-waking patterns and EEG activity in rats and rabbitsE Ongini, P Bo, S Dionisotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998
Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the ratA Monopoli, C Casati, G Lozza, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1995
Auditory impairment in guinea pigs treated with isepamicinL Fredelius, F Bamonte, S Dionisotti, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Pharmacology, Biochemistry, and Behavior|March 1, 1996
Effects of four antiepileptic drugs on sleep and waking in the rat under both light and dark phasesR Bertorelli, N Ferri, M Adami, et al.
Journal of Neurochemistry|March 7, 1998
[3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studiesB B Fredholm, K Lindström, S Dionisotti, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
Selective adenosine A2A receptor antagonistsE Ongini, A Monopoli, B Cacciari, et al.
European Journal of Pharmacology|February 26, 1991
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brainM Trampus, E Ongini, K Varani, et al.
European Journal of Pharmacology|June 7, 1985
Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the ratJ A Apud, C Masotto, E Ongini, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1987
SCH 23390 and its S-enantiomer stereoselectively prevent EEG and behavioral activation induced by dopamine agonists in the rabbitE Ongini, M G Caporali, M Massotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261S Dionisotti, S Ferrara, C Molta, et al.
Psychopharmacology|January 1, 1992
Effects of remoxipride, a dopamine D-2 antagonist antipsychotic, on sleep-waking patterns and EEG activity in rats and rabbitsE Ongini, P Bo, S Dionisotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998
Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the ratA Monopoli, C Casati, G Lozza, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1995
Auditory impairment in guinea pigs treated with isepamicinL Fredelius, F Bamonte, S Dionisotti, et al.
Pageof 14